医療レポート：Chronic Myeloid Leukemia-疫学予測（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.2.1 Exposure to ionizing radiation may not lead to the development of CML 10
3.2.2 Obesity and weight gain in adulthood play important roles in CML risk 11
3.3 Global Trends 12
3.3.1 Incidence 12
3.3.2 Prevalence and Survival 13
3.3.3 Mortality 14
3.4 Forecast Methodology 15
3.4.1 Sources Used 16
3.4.2 Forecast Assumptions and Methods, Incident Cases 17
3.4.3 Forecast Assumptions and Methods, Prevalent Cases 19
3.4.4 Sources Not Used 20
3.5 Epidemiological Forecast of Chronic Myeloid Leukemia (2012–2022) 20
3.5.1 Incident Cases of Chronic Myeloid Leukemia 20
3.5.2 Incident Cases of Chronic Myeloid Leukemia by Age Group 22
3.5.3 Incident Cases of Chronic Myeloid Leukemia by Sex 24
3.5.4 Age-Standardized Incidence Rates of Chronic Myeloid Leukemia 25
3.5.5 Incident Cases of Chronic Myeloid Leukemia with Ph+ 27
3.5.6 Incident Cases of Chronic Myeloid Leukemia by Phase at Diagnosis 28
3.5.7 Prevalent Cases of Chronic Myeloid Leukemia 29
3.6 Discussion 33
3.6.1 Epidemiological Forecast Insight 33
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 35
4 Appendix 36
4.1 Bibliography 36
4.2 About the Authors 39
4.2.1 Epidemiologists 39
4.2.2 Reviewers 40
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 40
4.2.4 Global Head of Healthcare 41
4.3 About GlobalData 42
4.4 About EpiCast 42
4.5 Contact Us 42
4.6 Disclaimer 43